Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab-Bevacizumab. Muto H, Kuzuya T, Tachi Y, Nagano Y, et al. Anticancer Res 2026;46:1609-1618.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Muto H, Kuzuya T, Tachi Y, Nagano Y, et al. Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab-Bevacizumab. Anticancer Res 2026;46:1609-1618.
PMID: 41760254